Bioventus BVS
NASDAQ BVS
$15.04 +0.80 (+5.62%)
At close: Oct 22, 2026 · 4:00 PM EDT

Bioventus (BVS) Amortization of Deferred Charges (2020 - 2021)

Updated

Analysis

Bioventus (BVS) Amortization of Deferred Charges (2020 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 250.06 Bn 229.21 Bn 4.88 Bn
2 Abbott Laboratories 177.62 Bn 148.71 Bn 7.27 Bn
3 Danaher 161.58 Bn 145.40 Bn 3.61 Bn
4 Intuitive Surgical 153.84 Bn 134.26 Bn 2.08 Bn
5 Medtronic 123.63 Bn 89.50 Bn 6.34 Bn
6 Stryker 117.79 Bn 103.90 Bn 4.50 Bn
7 Boston Scientific 66.71 Bn 61.72 Bn 3.85 Bn
8 Becton Dickinson 54.60 Bn 51.75 Bn 2.32 Bn
9 Edwards Lifesciences 51.95 Bn 36.07 Bn 1.35 Bn
10 Bioventus 1.26 Bn 1.15 Bn 105.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Apr 3, 2021 136,000.00
Mar 28, 2020 136,000.00
API Access

Bioventus Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=BVS&period=max&api_key=YOUR_API_KEY